369 related articles for article (PubMed ID: 24909161)
21. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
[TBL] [Abstract][Full Text] [Related]
22. EWS/FLI-1 oncoprotein subtypes impose different requirements for transformation and metastatic activity in a murine model.
González I; Vicent S; de Alava E; Lecanda F
J Mol Med (Berl); 2007 Sep; 85(9):1015-29. PubMed ID: 17453169
[TBL] [Abstract][Full Text] [Related]
23. The Fli-1 transcription factor regulates the expression of CCL5/RANTES.
Lennard Richard ML; Sato S; Suzuki E; Williams S; Nowling TK; Zhang XK
J Immunol; 2014 Sep; 193(6):2661-8. PubMed ID: 25098295
[TBL] [Abstract][Full Text] [Related]
24. Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia.
Cui JW; Vecchiarelli-Federico LM; Li YJ; Wang GJ; Ben-David Y
Leukemia; 2009 Jul; 23(7):1311-9. PubMed ID: 19282832
[TBL] [Abstract][Full Text] [Related]
25. Reversible LSD1 inhibition interferes with global EWS/ETS transcriptional activity and impedes Ewing sarcoma tumor growth.
Sankar S; Theisen ER; Bearss J; Mulvihill T; Hoffman LM; Sorna V; Beckerle MC; Sharma S; Lessnick SL
Clin Cancer Res; 2014 Sep; 20(17):4584-97. PubMed ID: 24963049
[TBL] [Abstract][Full Text] [Related]
26. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
[TBL] [Abstract][Full Text] [Related]
27. Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.
Elzi DJ; Song M; Hakala K; Weintraub ST; Shiio Y
J Proteome Res; 2014 Aug; 13(8):3783-91. PubMed ID: 24999758
[TBL] [Abstract][Full Text] [Related]
28. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1.
May WA; Lessnick SL; Braun BS; Klemsz M; Lewis BC; Lunsford LB; Hromas R; Denny CT
Mol Cell Biol; 1993 Dec; 13(12):7393-8. PubMed ID: 8246959
[TBL] [Abstract][Full Text] [Related]
29. EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma.
Owen LA; Kowalewski AA; Lessnick SL
PLoS One; 2008 Apr; 3(4):e1965. PubMed ID: 18414662
[TBL] [Abstract][Full Text] [Related]
30. A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis.
Leacock SW; Basse AN; Chandler GL; Kirk AM; Rakheja D; Amatruda JF
Dis Model Mech; 2012 Jan; 5(1):95-106. PubMed ID: 21979944
[TBL] [Abstract][Full Text] [Related]
31. PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors.
Zwerner JP; May WA
Oncogene; 2001 Feb; 20(5):626-33. PubMed ID: 11313995
[TBL] [Abstract][Full Text] [Related]
32. EWS-FLI-1 regulates the neuronal repressor gene REST, which controls Ewing sarcoma growth and vascular morphology.
Zhou Z; Yu L; Kleinerman ES
Cancer; 2014 Feb; 120(4):579-88. PubMed ID: 24415532
[TBL] [Abstract][Full Text] [Related]
33. Ewing's sarcoma: general insights from a rare model.
Davis S; Meltzer PS
Cancer Cell; 2006 May; 9(5):331-2. PubMed ID: 16697953
[TBL] [Abstract][Full Text] [Related]
34. Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation.
Tamir A; Howard J; Higgins RR; Li YJ; Berger L; Zacksenhaus E; Reis M; Ben-David Y
Mol Cell Biol; 1999 Jun; 19(6):4452-64. PubMed ID: 10330185
[TBL] [Abstract][Full Text] [Related]
35. Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.
Stegmaier K; Wong JS; Ross KN; Chow KT; Peck D; Wright RD; Lessnick SL; Kung AL; Golub TR
PLoS Med; 2007 Apr; 4(4):e122. PubMed ID: 17425403
[TBL] [Abstract][Full Text] [Related]
36. Ets and retroviruses - transduction and activation of members of the Ets oncogene family in viral oncogenesis.
Blair DG; Athanasiou M
Oncogene; 2000 Dec; 19(55):6472-81. PubMed ID: 11175363
[TBL] [Abstract][Full Text] [Related]
37. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
[TBL] [Abstract][Full Text] [Related]
38. Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis.
Showpnil IA; Miller KR; Taslim C; Pishas KI; Lessnick SL; Theisen ER
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32658189
[TBL] [Abstract][Full Text] [Related]
39. Expression of EWS-ETS fusions in NIH3T3 cells reveals significant differences to Ewing's sarcoma.
Braunreiter CL; Hancock JD; Coffin CM; Boucher KM; Lessnick SL
Cell Cycle; 2006 Dec; 5(23):2753-9. PubMed ID: 17172842
[TBL] [Abstract][Full Text] [Related]
40. An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes.
Zhang L; Eddy A; Teng YT; Fritzler M; Kluppel M; Melet F; Bernstein A
Mol Cell Biol; 1995 Dec; 15(12):6961-70. PubMed ID: 8524263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
